Attached files
file | filename |
---|---|
10-K - 10-K - Phathom Pharmaceuticals, Inc. | phat-10k_20201231.htm |
EX-32.2 - EX-32.2 - Phathom Pharmaceuticals, Inc. | phat-ex322_1449.htm |
EX-32.1 - EX-32.1 - Phathom Pharmaceuticals, Inc. | phat-ex321_1450.htm |
EX-31.2 - EX-31.2 - Phathom Pharmaceuticals, Inc. | phat-ex312_1447.htm |
EX-31.1 - EX-31.1 - Phathom Pharmaceuticals, Inc. | phat-ex311_1411.htm |
EX-23.1 - EX-23.1 - Phathom Pharmaceuticals, Inc. | phat-ex231_1974.htm |
EX-10.22 - EX-10.22 - Phathom Pharmaceuticals, Inc. | phat-ex1022_2100.htm |
EX-10.21 - EX-10.21 - Phathom Pharmaceuticals, Inc. | phat-ex1021_1410.htm |
EX-10.20 - EX-10.20 - Phathom Pharmaceuticals, Inc. | phat-ex1020_1409.htm |
EX-4.6 - EX-4.6 - Phathom Pharmaceuticals, Inc. | phat-ex46_8.htm |
Exhibit 24.1
LIMITED POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person or entity whose signature appears below constitutes, designates and appoints each of Terrie Curran and Larry Miller, each of whom are officers of Phathom Pharmaceuticals, Inc. (the “Company”), as its true and lawful attorneys-in-fact and agent, each with power of substitution, with full power to act without the other and on behalf of and as attorney for me, for the purpose of executing and filing with the Securities and Exchange Commission the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto, and to do all such other acts and execute all such other instruments which said attorney may deem necessary or desirable in connection therewith.
Signature |
Title |
Date |
/s/ Michael Cola Michael Cola |
Director |
March 10, 2021
|
/s/ Heidi Kunz Heidi Kunz |
Director |
March 11, 2021
|
/s/ Asit Parikh Asit Parikh |
Director |
March 11, 2021
|
/s/ David Socks David Socks |
Director |
March 10, 2021
|
/s/ Mark Stenhouse Mark Stenhouse |
Director |
March 10, 2021
|
/s/ James Topper James Topper |
Director |
March 10, 2021
|
/s/ Tadataka Yamada Tadataka Yamada |
Director |
March 10, 2021
|